Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the number of warrants outstanding as of June 30, 2022 and December 31, 2021:


	Liability Classified							Equity Classified
	Number of Shares			Weighted Average Exercise Price (C$)		Weighted Average Remaining Contractual Life		Number of Shares			Weighted Average Exercise Price (USD)		Weighted Average Remaining Contractual Life
Balance as of December 31, 2021		2,097,931	C$		18.26		2.42		1,737,347	$		31.83		4.38
Balance as of June 30, 2022		2,097,931	C$		18.26		1.92		1,737,347	$		31.83		3.88

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 14 - Fair Value Measurements for additional details):


	June 30,	December 31,
Significant Assumptions	2022	2021
Volatility	62.23% - 68.30%	59.95% - 74.04%
Remaining Term	0.28 - 2.89 years	0.78 - 3.39 years
Risk Free Rate	3.09% - 3.14%	0.91% - 1.06%

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date:


Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Dispensary Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%